GENFIT begins phase 3 trial of elafibranor in primary biliary cholangitis

GENFIT has started the phase 3 ELATIVE clinical trial for evaluating the efficacy and safety of elafibranor for the treatment of primary biliary cholangitis (PBC). ... Read More